Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]
Home »

#VisualAbstract: Empagliflozin does not significantly reduce the risk of heart failure or death in patients after acute myocardial infarction

Apr 26, 2024

ABOUT THE EXPERTS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


RELEVANT ARTICLES FOR YOU

Advertisement
[adinserter block="6" template="Article Pages" check="exceptions" ignore="page-type"]